Skip to main content
SpringerLink
Log in
Book cover

Clinical Hepatology pp 425–436Cite as

Nuclear Imaging

  • Chapter

  • 1826 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Abdel-Nabi H, Dörr RJ, Lamonica DM, et al (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorode-oxyglucose whole-body PET: correlation with histopatho-logic and CT findings. Radiology 206: 755–60

    CAS  PubMed  Google Scholar 

  2. Anderson CJ, Dehdashti F, Cutler PD, et al (2001) 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 42: 213–21

    CAS  PubMed  Google Scholar 

  3. Anderson CD, Rice MH, Pinson CW, et al (2004) Fluorode-oxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8: 90–7

    Article  PubMed  Google Scholar 

  4. Antoch G, Vogt FM, Veit P, et al (2005) Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 46: 520–5

    PubMed  Google Scholar 

  5. Arulampalam TH, Francis DL, Visvikis D, et al (2004) FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 30: 286–91

    CAS  PubMed  Google Scholar 

  6. Bares R, Lucignani G (1996) Clinical PET. Klüwer, Dordrecht/ Boston/London

    Google Scholar 

  7. Barker DW, Zagoria RJ, Morton KA, et al (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. Am J Roentgenol 184: 1096–1102

    Google Scholar 

  8. Becker W (1992) Entzündungsdiagnostik mit autologen Leukozyten und murinen monoklonalen Antikörpern. Nuklearmediziner 4: 273–86

    Google Scholar 

  9. Böhm B, Voth M, Geoghegan J, et al (2004) Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 130: 266–72

    Article  PubMed  Google Scholar 

  10. Chen CC (1996) The biliary System. In: Harbert JC, Eckelman WC, Neumann RD (eds) Nuclear medicine: diagnosis and therapy. Thieme, New York/Stuttgart, pp 685–705

    Google Scholar 

  11. Cohade C, Osman M, Leal J, et al (2003) Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44: 1797–803

    PubMed  Google Scholar 

  12. Cook GJR, Maisey MN, Fogelman I (1999). Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 26: 1363–78

    Article  CAS  PubMed  Google Scholar 

  13. Delbeke D, Martin WH, Sandler MP, et al (1998) Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133: 510–6

    Article  CAS  PubMed  Google Scholar 

  14. Dresel S, Kirsch CM, Tatsch K, et al (1997) Detection of hepatocellular Carcinoma with a new alpha-fetoprotein antibody imaging kit. J Clin Oncol 15: 2683–90

    CAS  PubMed  Google Scholar 

  15. Fritscher-Ravens A, Bohuslavizki KH, Bröring DC, et al (2001) FDG PET in the diagnosis of hilar cholangiocarci-noma. Nucl Med Commun 22: 1277–85

    Article  CAS  PubMed  Google Scholar 

  16. Harbert JC (1996) The liver. In: Harbert JC, Eckelman WC, Neumann RD (eds) Nuclear medicine: diagnosis and therapy. Thieme, New York/Stuttgart, pp 651–83

    Google Scholar 

  17. Helmberger T, Holzknecht H, Gregor M, et al (1998) Fokale Lebererkrankungen. Radiologe 38: 263–9

    Article  CAS  PubMed  Google Scholar 

  18. Ho CL, Yu SC, Yeung DW (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44: 213–21

    PubMed  Google Scholar 

  19. Hofmann M, Mäcke H, Börner R, et al (2001) Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med 28: 1751–7

    Article  CAS  PubMed  Google Scholar 

  20. Hübner RH, Park KC, Shepherd JE, et al (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41: 1177–89

    Google Scholar 

  21. Keiding S, Munk OL, Schiott KM, et al (2000) Dynamic 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography of liver tumours without blood sampling. Eur J Nucl Med 27: 407–12

    Article  CAS  PubMed  Google Scholar 

  22. Khan MA, Combs CS, Brunt EM, et al (2000) Positron emission tomography scanning in the evaluation of hepato-cellular carcinoma. J Hepatol 32: 792–7

    Article  CAS  PubMed  Google Scholar 

  23. Kinkel K, Lu Y, Both M, et al (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using non-invasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224: 748–56

    Article  PubMed  Google Scholar 

  24. Kluge R, Schmidt F, Caca K, et al (2001) Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33: 1029–35

    Article  CAS  PubMed  Google Scholar 

  25. Koukouraki S, Strauss LG, Georgoulias V, et al (2006) Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 33: 1115–22

    Article  CAS  PubMed  Google Scholar 

  26. Kowalski J, Henze M, Schuhmacher J, et al (2003) Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 5: 42–8

    Article  PubMed  Google Scholar 

  27. Krause T, Hauenstein K, Studier-Fischer B, et al (1993) Improved evaluation of technetium-99m-red blood cell SPECT in hemangioma of the liver. J Nucl Med 23: 375–80

    Google Scholar 

  28. Lai DT, Fulham M, Stephen MS, et al (1996) The role of whole-body positron emission tomography with [18F]fluoro-deoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131: 703–7

    CAS  PubMed  Google Scholar 

  29. Lassmann M, Biassoni L, Monsieurs M, et al (2007) The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging 34: 796–8

    Article  CAS  PubMed  Google Scholar 

  30. Meisetschläger G, Poethko T, Stahl A, et al (2006) Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide. J Nucl Med 47: 566–73

    PubMed  Google Scholar 

  31. Menzel J, Schober O, Reimer P, et al (1997) Scintigraphic evaluation of hepatic hemodynamics after intrahepatic porto-systemic shunt (TIPS). Eur J Nucl Med 24: 635–41

    CAS  PubMed  Google Scholar 

  32. Middelton ML (1996) Scintigraphic evaluation of hepatic mass lesions: emphasis on hemangioma detection. Semin Nucl Med 26: 4–15

    Article  Google Scholar 

  33. Nadel HR (1996) Hepatobiliary scintigraphy in children. Semin Nucl Med 26: 25–42

    Article  CAS  PubMed  Google Scholar 

  34. Negrin JA, Zanzi I, Margouleff D (1995) Hepatobiliary scin-tigraphy after biliary tract surgery. Sem Nucl Med 25: 28–35

    Article  CAS  Google Scholar 

  35. Olsen JO, Pozderac RV, Hinkle G, et al (1995) Somatostatin receptor imaging of neuroendocrine tumors with Indium-111-pentetreotide (OctreoScan). Semin Nucl Med 25: 251–61

    Article  CAS  PubMed  Google Scholar 

  36. Petrowsky H, Wildbrett P, Husarik DB, et al (2006) Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45: 43–50

    Article  PubMed  Google Scholar 

  37. Prytz H, Keiding S, Björnsson E, et al (2006) Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology 44: 1572–80

    Article  CAS  PubMed  Google Scholar 

  38. Reske SN, Kotzerke J (2001) FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, “Onko-PET III”, 21 July and 19 September 2000. Eur J Nucl Med 28: 1707–23

    Article  CAS  PubMed  Google Scholar 

  39. Riemann B, Weßling J (2008) Tumoren der Leber und des unteren Verdauungstrakts. In: Schober O, Heindel W (Hrsg) PET-CT. Thieme, Stuttgart, pp. 234–40

    Google Scholar 

  40. Risse JH, Grünwald F, Kersjes W, et al (2000) Intraarterial HCC therapy with I-131-Lipiodol. Cancer Biother Radiopharm 15: 65–70

    Article  CAS  PubMed  Google Scholar 

  41. Rosenbaum SJ, Stergar H, Antoch G, et al (2006) Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging 31: 25–35

    Article  CAS  PubMed  Google Scholar 

  42. Rubin RA, Lichtenstein GR (1993) Hepatic scintigraphy in the evaluation of solitary solid liver masses. J Nucl Med 34: 697–705

    CAS  PubMed  Google Scholar 

  43. Schillaci O, Scopinaro F, Angeletti S, et al (1996) SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med 37: 1452–6

    CAS  PubMed  Google Scholar 

  44. Schober O (2001) Gastrointestinaltrakt. In: Büll U, Schicha H, Biersack HJ, Knapp WH, Reiners Chr, Schober O (eds) (Hrsg) Nuklearmedizin. Thieme, Stuttgart/New York, pp 365–89

    Google Scholar 

  45. Schober O, B. Riemann (2007) Leber — Milz. In: Schicha H, Schober O (eds) (Hrsg) Nuklearmedizin. Schattauer, Stuttgart/ New York, pp 234–40

    Google Scholar 

  46. Selzner M, Hany TF, Wildbrett P, et al (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240: 1027–34

    Article  PubMed  Google Scholar 

  47. Shah AN, Dodson F, Fung J (1995) Role of nuclear medicine in liver transplantation. Semin Nucl Med 25: 36–48

    Article  CAS  PubMed  Google Scholar 

  48. Sugiyama M, Sakahara H, Torizuka T, et al (2004) 18F-FDG PET in the detection of extrahepatic metastases from hepato-cellular carcinoma. J Gastroenterol 39: 961–968

    Article  CAS  PubMed  Google Scholar 

  49. Topal B, Flamen P, Aerts R, et al (2001) Clinical value of whole-body emission tomography in potentially curable col-orectal liver metastases. Eur J Surg Oncol 27: 175–9

    Article  CAS  PubMed  Google Scholar 

  50. Torizuka T, Tamaki N, Inokuma T, et al (1994) Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 35: 1965–9

    CAS  PubMed  Google Scholar 

  51. Torizuka T, Tamaki N, Inokuma T, et al (1995) In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 36: 1811–7

    CAS  PubMed  Google Scholar 

  52. Vitola J V, Delbeke D, Meranze SG, et al (1996) Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 78: 2216–22

    Article  CAS  PubMed  Google Scholar 

  53. Wernecke K, Rummeny E, Bongartz G, et al (1991) Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT and MRI. Am J Radiol 157: 731–9

    CAS  Google Scholar 

  54. Yang M, Martin DR, Karabukut N, et al (2003) Comparison of MR and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging 17: 343–9

    Article  PubMed  Google Scholar 

  55. Ziessmann HA, Silverman PM, Patterson J, et al (1991) Improved detection of small cavernous hemangiomas of the liver with high-resolution three-headed SPECT. J Nucl Med 32: 2086–91

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Westfälische Wilhelms-Universität, Albert-Schweitzer-Strasse 33, Mënster, 48149, Germany

    Burkhard Riemann & Otmar Schober

Authors
  1. Burkhard Riemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Otmar Schober
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Riemann, B., Schober, O. (2010). Nuclear Imaging. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-93842-2_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-93842-2_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-93841-5

  • Online ISBN: 978-3-540-93842-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation